Characterization of parameters required for effective use of tamoxifen-regulated recombination

PLoS ONE

Volumn 3, Issue 9, 2008, Pages

  Buelow, Ben ^a   Scharenberg, Andrew M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; INTEGRASE; LIGAND; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ANIMAL; ARTICLE; B LYMPHOCYTE; BIOLOGICAL MODEL; CHICKEN; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC RECOMBINATION; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; TRANSGENE;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CHICKENS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE TARGETING; INTEGRASES; LIGANDS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; RECOMBINATION, GENETIC; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TRANSGENES;

EID: 54749141157     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003264     Document Type: Article

References (37)

1. Branda CS, Dymecki SM (2004), Talking about a revolution: The impac of site-specific recombinases on genetic analyses in mice. Dev Cell 6: 7-28.
2. Glaser S, Anastassiadis K, Stewart AF (2005), Current issues in mouse genome engineering. Nat Genet 37: 1187-1193.
3. Schmidt-Supprian M, Rajewsky K (2007), Vagaries of conditional gene targeting. Nat Immunol 8: 665-668.
4. Semprini S, Troup TJ, Kotelevtseva N, King K, Davis JR, et al. (2007) Cyptic loxP sites in mammalian genomes: genome-wide distribution and relevance for the efficiency of BAC/PAC recombineering techniques. Nucleic Acids Res 35: 1402-1410.
5. Thyagarajan B, Guimaraes MJ, Groth AC, Calos MP (2000) Mammalian genomes contain active recombinase recognition sites. Gene 244: 47-54.
6. Rajewsky K, Gu H, Kuhn R, Betz UA, Muller W, et al. (1996), Conditional gene targeting. J Clin Invest 98: 600-603.
7. Metzger D, Chambon P (2001), Site- and time-specific gene targeting in the mouse. Methods 24: 71-80.
8. Lee JY, Ristow M, Lin X, White MF, Magnuson MA, et al. (2006) RIP-Cre revisited, evidence for impairments of pancreatic beta-cell function. J Biol Chem 281: 2649-2653.
9. (2007) Toxic alert. Nature 449: 378.
10. de Alboran IM, O'Hagan RC, Gartner F, Malynn B, Davidson L, et al. (2001) Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 14: 45-55.
11. Loonstra A, Vooijs M, Beverloo HB, Allak BA, van Drunen E, et al. (2001) Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Acad Acad Sci U S A 98: 9209-9214.
12. Pfeifer A, Brandon EP, Kootstra N, Gage FH, Verma IM (2001) Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo. Proc Natl Acad Sci U S A 98: 11450-11455.
13. Baba Y, Nakano M, Yamada Y, Saito I, Kanegae Y (2005) Practical range of effective dose for Cre recombinase-expressing recombinant adenovirus without cell toxicity in mammalian cells. Microbiol Immunol 49: 559-570.
14. Forni PE, Scuoppo C, Imayoshi I, Taulli R, Dastru W, et al. (2006) High levels of Cre expression in neuronal progenitors cause defects in brain development leading to microencephaly and hydrocephaly. J Neurosci 26: 9593-9602.
15. Badea TC, Wang Y, Nathans J (2003), A Noninvasive Genetic/Pharmacologic Strategy for Visualizing Cell Morphology and Clonal Relationships in the Mouse. J Neuroscience 23: 2314-2322.
16. Zervas M, Millet S, Ahn S, Joyner AL (2004) Cell Behaviors and Genetic Lineages of the Mesencephalon and Rhombomere 1. Neuron 43: 345-357.
17. Matsuda T, Cepko CL (2007) Controlled expression of transgenes introduced by in vivo electroporation. PNAS 104: 1027-1032.
18. Ahn S, Joyner LJ (2005) In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog. Nature 437: 894-897.
19. Bree RT, Lai XY, Canavan LE, Lowndes NF 2007, Comparisons between DT40 wildtype and DT40-Crel cells as suitable model systems for studying the DNA damage response. Cell Cycle 6: 2310-2313.
20. Zhang Y, Riesterer C, Ayrall AM, Sablitzky F, Littlewood TD, et al. (1996) Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res 24: 543-548.
21. Heidmann D, Lehner CF (2001), Reduction of Cre recombinase toxicity in proliferating Drosophila cells by estrogen-dependent activity regulation. Dev Genes Evol 211: 458-465.
22. Feil R, Wagner J, Metzger D, Chambon P (1997), Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun 237: 752-757.
23. Fell R, Brocard J, Mascrez B, LeMeur M, Metzger D, et al. (1996) Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci U S A 93: 10887-10890.
24. Kanayama N, Todo K, Reth M, Ohmori H (2005) Reversible switching of immunoglobulin hypermutation machinery in a chicken B cell line. Biochem Biophys Res Commun 327: 70-75.
25. Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, et al. (2001), Temporally Regulated and Tissue-Specific Gene Manipulations in the Adult and Embryonic Heart Using a Tamoxifen-Inducible Cre Protein. Circ Res 89: 20-25.
26. Balordi F, Fishell G (2007) Mosaic Removal of Hedgehog Signaling in the Adult SVZ Reveals That the Residual Wild-Type Stem Cells Have a Limited Capacity for Self-Renewal. J Neuroscience 27: 14248-14259.
27. Hayashi S, McMahon AP (2002) Efficient Recombination in Diverse Tissues by a Tamoxifen-Inducible Form of Cre: A Tool for Temporally Regulated Gene Activation/Inactivation in the Mouse. Developmental Biology 244: 305-318.
28. Buerstedde JM, Takeda S (1991), Increased ratio of targeted to random integration after transfection of chicken B cell lines. Cell 67: 179-188.
29. Lahti JM (1999) Use of gene knockouts in cultured cells to study apoptosis. Methods 17: 305-312.
30. Alinikula J, Lassila O, Nera KP (2006) DT40 mutans: a model to study transcriptional regulation of B cell development and function. Subcell Biochem 40: 189-205.
31. Shinohara H, Kurosaki T (2006) Genetic analysis of B cell signaling. Subcell Biochem 40: 145-187.
32. Rainey MD, Zachos G, Gillespie DA (2006) Analysing the DNA damage and replication checkpoints in DT40 cells. Subcell Biochem 40: 107-117.
33. Okada M, Hori T, Fukagawa T (2006) The DT40 system as a tool for analyzing kinetochore assembly. Subcell Biochem 40: 91-106.
34. Caldwell RB, Kierzek AM (2006) Genome resources for the DT40 community. Subcell Biochem 40: 25-37.
35. Nadler MJ, Hermosura MC, Inabe K, Perraud AL, Zhu Q et al. (2001) LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature 411: 590-595.
36. Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI (1995) A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res 23: 1686-1690.
37. Vooijs M, Jonkers J, Berns A (2001) A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep 2: 292-297.